Form 4 for CMPX Compass Therapeutics, Inc.
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0000899243-21-045310 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-18 | 2021-11-16 | CMPX | Schuetz Thomas J. | CEO, Dir | A - Grant | $0.00 | +600.0K | 5.13M | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | A | A | 600,000 | $0.00 | 5,125,467 | D | — | — | (F1) Represents restricted stock units ("RSU") granted to the reporting person on November 16, 2021. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vesting on November 15, 2022. |